Vanguard Asset Management’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.52M Buy
141,036
+16,529
+13% +$611K ﹤0.01% 1100
2026
Q2
$4.82M Buy
124,507
+36,890
+42% +$1.29M ﹤0.01% 1066
2026
Q1
$3.37M Buy
+87,617
New +$3.24M ﹤0.01% 1174

Other funds holding COGT

Vanguard Asset Management's COGT Position: Q3 2026 in Review

Vanguard Asset Management increased its Cogent Biosciences (COGT) stake by 13% in Q3 2026, buying an estimated $611K and bringing the position to 141,036 shares worth $4.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1100.

Vanguard Asset Management first reported a position in COGT in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.82M in Q2 2026. 316 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Vanguard Asset Management held 141,036 shares of Cogent Biosciences worth $4.52M as of Q3 2026.
  • Vanguard Asset Management bought 16,529 Cogent Biosciences shares in Q3 2026, an estimated $611K.
  • Cogent Biosciences made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1100 holding.
  • Vanguard Asset Management first reported a position in Cogent Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Asset Management's Cogent Biosciences position peaked at $4.82M in Q2 2026.
  • 316 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.